Wolverine Trading
APTO

Wolverine Trading’s Aptose Biosciences, Inc. APTO Stock Holding History

Wolverine Trading’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30
Closed -$17K – 6099
2022
Q1 		$17K Buy
+30
New +$16.6K ﹤0.01% 5266
2021
Q4 		– Sell
-39
Closed -$40K – 7191
2021
Q3 		$40K Sell
39
-18
-32% -$22.5K ﹤0.01% 6056
2021
Q2 		$87K Buy
57
+2
+4% +$4.36K ﹤0.01% 5463
2021
Q1 		$153K Sell
55
-3
-5% -$5.95K ﹤0.01% 5229
2020
Q4 		$111K Buy
+58
New +$136K ﹤0.01% 4439

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $88.2M AUM 25.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wolverine Trading's APTO Position: Q4 2021 in Review

Wolverine Trading sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 33 shares — an estimated $35K sold.

Wolverine Trading first reported a position in APTO in Q3 2021 and held it in 1 quarter. The position peaked at $35K in Q3 2021. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

  • Wolverine Trading reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 33 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $35K.
  • Wolverine Trading first reported a position in Aptose Biosciences, Inc. in Q3 2021 and held it in 1 quarter.
  • Wolverine Trading's Aptose Biosciences, Inc. position peaked at $35K in Q3 2021.
  • 58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.